Recently, Sinopharm Engineering and Baiotai Biopharmaceutical Co., Ltd. formally signed a cooperation agreement to jointly promote the second phase of the construction project of Baiotai.‐.

The project is located in Huangpu District, Guangzhou City, with a planned land area of about46000 square meters-with a total construction area of about 83000 square meters, it is planned to add an intelligent 36000-litre antibody stock solution production platform, an intelligent pre-filling injection production line, a vials high-speed filling preparation line and its supporting facilities and equipment. Through the integration of continuous flow technology, closed production system and collaborative innovation of intelligent control platform, Sinopharm Engineering has built a new mode of efficient, safe and intelligent biopharmaceutical production.

In the future, the National Pharmaceutical Project will continue to deepen its strategic synergy with Baiotai, with Guangzhou Huangpu Base as its innovation fulcrum, relying on its professional advantages in the field of biopharmaceutical engineering construction, to help Guangdong, Hong Kong and Macao to build a world-class biomedical industry highland and promote China's innovative drugs to the world.

(Guangzhou Company)